Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCl in vitro

Free Radical Biology and Medicine

Volumn 23, Issue 1, 1997, Pages 82-89

  Yang, Chao Yuh ^a,b   Gu, Zi Wei ^a   Yang, Hui Xin ^a   Yang, Manlan ^a   Gotto Jr , Antonio M ^a   Smith, Charles V ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

2,4 Dinitrophenylhydrazine; apoB 100; Free radicals; HOCl; hypochlorous acid; LDL; Low density lipoproteins; Oxidized LDL peptides; Protein carbonyls

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; APOLIPOPROTEIN B100; HYDRAZONE DERIVATIVE; LOW DENSITY LIPOPROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; QUANTITATIVE DIAGNOSIS; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIPOPROTEINS, LDL; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PHENYLHYDRAZINES; SODIUM HYPOCHLORITE; TRYPSIN;

EID: 0030950291     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00624-7     Document Type: Article

References (37)

1. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
2. Steinbrecher U. P., Zhang H., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med. 9:1990;155-168.
3. Stocker R. Lipoprotein oxidation: Mechanistic aspects, methodological approaches and clinical relevance. Curr. Opin. Lipid. 5:1994;422-433.
4. Berliner J. A., Navab M., Fogelman A. M., Frank J. S., Demer L. L., Edwards P. A., Watson A. D., Lusis A. J. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
5. Brown M. S., Goldstein J. L. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Ann. Rev. Biochem. 52:1983;223-261.
6. Haberland M. E., Smith C. V. Lipid peroxide-dependent modifications of lipoproteins in atherosclerosis. Moslen M. T., Smith C. V. Free radical mechanisms of tissue injury. 1992;45-64 CRC Press, Boca Raton.
7. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
8. Steinberg D., Witztum J. L. Lipoproteins and atherogenesis: Current concepts. JAMA. 264:1990;3047-3052.
9. Jeng J. R., Chang C. H., Shieh S. M., Chiu H. C. Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear stress-induced detachment. Biochim. Biophys. Acta. 1178:1993;221-227.
10. Morel D. W., DiCorleto P. E., Chisolm G. M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:1984;357-364.
11. Guyton J. R., Lenz M. L., Mathews B., Hughes H., Karsan D., Selinger E., Smith C. V. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis. 118:1995;237-249.
12. Lenz M. L., Hughes H., Mitchell J. R., Via D. P., Guyton J. R., Taylor A. A., Gotto A. M. Jr., Smith C. V. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J. Lipid Res. 31:1990;1043-1050.
13. Sakai M., Miyazaki A., Hakamata H., Sato Y., Matsumura T., Kobori S., Shichiri M. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 16:1996;600-605.
14. Quinn M. T., Parthasarathy S., Fong L. G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:1987;2995-2998.
15. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
16. Sattler W., Kostner G. M., Waeg G., Esterbauer H. Oxidation of lipoprotein Lp[a]. A comparison with low-density lipoproteins. Biochim. Biophys. Acta. 1081:1991;65-74.
17. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
18. Hazell L. J., van den Berg J. J. M., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302:1994;297-304.
19. Hazell L. J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:1993;165-172.
20. Daugherty A., Dunn J. L., Rateri D. L., Heinecke J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1994;437-444.
21. Hazell L. J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.
22. Stadtman E. R. Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9:1990;315-325.
23. Levine R. L., Williams J. A., Stadtman E. R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Meth. Enzymol. 233:1994;346-357.
24. Gladstone I. M., Levine R. L. Oxidation of proteins in neonatal lungs. Pediatrics. 93:1994;764-768.
25. Fieser L. F., Fieser M. Reagents for organic synthesis. 1967;John Wiley and Sons, Inc, New York.
26. Shacter E., Williams J. A., Lim M., Levine R. L. Differential susceptibility of plasma proteins to oxidative modification: Examination by Western blot immunoassay. Free Radic. Biol. Med. 17:1994;429-437.
27. Yang C.-Y., Gu Z.-W., Weng S.-a., Kim T. W., Chen S.-H., Pownall H. J., Sharp P. M., Liu S.-W., Li W.-H., Gotto A. M. Jr., Chan L. Structure of apolipoprotein B-100 of human low density lipoproteins. Arteriosclerosis. 9:1989;96-108.
28. Frenkel K., Blum F., Troll W. Copper ions and hydrogen peroxide form hypochlorite from NaCl thereby mimicking myeloperoxidase. J. Cell. Biochem. 30:1986;181-193.
29. Winterbourn C. C. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride and similarity of the oxidant to hypochlorite. Biochim. Biophys. Acta. 840:1985;204-210.
30. Mahley R. W., Innerarity T. L., Pitas R. E., Weisgraber K. H., Brown K. H., Gross E. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residue in arginine-rich and B apoproteins. J. Biol. Chem. 252:1977;7279-7287.
31. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
32. Xu X. X., Tabas I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesterol ester accumulation in macrophages. J. Biol. Chem. 266:1991;24849-24858.
33. Hoff H. J., O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler. Thromb. 11:1991;1209-1222.
34. Yang C. Y., Kim T. W., Weng S. A., Lee B., Yang M., Gotto A. M. Jr. Isolation and characterization of sulfhydryl and disulfide peptides of human apoB-100. Proc. Natl. Acad. Sci. USA. 87:1990;5523-5527.
35. Coleman R. D., Kim T. W., Gotto A. M. Jr., Yang C. Y. Determination of cysteine on low density lipoproteins using the fluorescent probe 5-iodoacetamidofluoresceine. Biochim. Biophys. Acta. 1037:1989;123-132.
36. Stadtman E. R. Role of oxidized amino acids in protein breakdown and stability. Meth. Enzymol. 258:1995;379-393.
37. Burlett O., Yang C.-Y., Guyton J. R., Gaskell S. J. Tandem mass spectrometric characterization of a specific cysteic acid residue in oxidized human apoprotein B-100. J. Am. Soc. Mass Spectrom. 6:1995;242-247.